V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20167666 | 20063952 | 1.63 | 51 | Curative (C) | 2016-02-27 | 2016-02-27 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | N | FLUOROURACIL | 100000001 |
| 40099781 | 40071453 | 1.61 | 58 | Neo-adjuvant (N) | 2018-11-18 | 2018-12-04 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100000003 |
| 20157804 | 20117056 | 1.64 | 62.9 | null | 2018-09-23 | 2018-09-29 | GEMCITABINE | 02 | null | GEMCITABINE | 100000015 |
| 20157804 | 20060310 | 1.76 | 75.8 | Neo-adjuvant (N) | 2018-05-21 | 2018-06-15 | ECX | N | N | ECX | 100000015 |
| 40153254 | 40109670 | 1.61 | 53.2 | Adjuvant (A) | 2016-12-14 | 2017-01-14 | Trastuzumab | 02 | N | TRASTUZUMAB | 100000021 |
| 40141020 | 40237072 | 1.58 | 46.9 | null | 2014-12-23 | 2016-12-11 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100000034 |
| 40141020 | 40271422 | 1.58 | 96 | null | 2016-11-19 | 2016-12-12 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100000034 |
| 40141020 | 40183209 | 1.53 | 64.95 | Adjuvant (A) | 2016-12-11 | 2016-12-11 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100000034 |
| 40141020 | 40100956 | 1.71 | 50.3 | Adjuvant (A) | 2016-09-05 | 2016-09-26 | PACLITAXEL | 02 | N | PACLITAXEL | 100000034 |
| 40134049 | 40233448 | 1.47 | 56.6 | Adjuvant (A) | 2020-12-14 | 2021-05-07 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100000036 |
| 40134049 | 40096030 | 1.65 | 70.4 | Curative (C) | 2019-05-19 | 2019-05-28 | FEC + DOCETAXEL | N | N | FEC + DOCETAXEL | 100000036 |
| 70044779 | 70032195 | null | null | Curative (C) | 2021-08-19 | 2021-08-24 | Rituximab | 2 | N | RITUXIMAB | 100000045 |
| 70020635 | 70119255 | 1.7 | 47 | null | null | 2022-03-12 | Rituximab | 02 | null | RITUXIMAB | 100000051 |
| 70020635 | 70079045 | null | 55.2 | null | 2018-12-13 | 2018-12-13 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | RITUXIMAB | 100000051 |
| 70020635 | 70015832 | 1.77 | 86.5 | Curative (C) | 2018-12-09 | 2018-12-13 | CHOP R - 21 days | N | N | CHOP R | 100000051 |
| 20188991 | 20070169 | 1.62 | 72.6 | Palliative (P) | 2017-05-08 | 2017-05-09 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100000054 |
| 20127106 | 20042765 | 1.54 | 79.6 | Palliative (P) | 2018-11-06 | 2018-11-13 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100000056 |
| 40107021 | 40076664 | 1.53 | 96.4 | Adjuvant (A) | 2018-10-22 | 2018-10-23 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100000067 |
| 30173828 | 30085219 | 0 | 0 | null | 2021-09-17 | 2021-09-25 | Enzalutamide | 02 | null | ENZALUTAMIDE | 100000082 |
| 40151952 | 40108731 | null | 80.1 | Neo-adjuvant (N) | 2019-12-05 | 2019-12-19 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100000086 |
| 40151952 | 40190348 | 1.67 | 66.65 | Neo-adjuvant (N) | 2019-12-23 | 2020-02-08 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100000086 |
| 70003961 | 70002989 | 1.81 | 84.4 | Curative (C) | 2018-06-22 | 2018-07-06 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100000093 |
| 60078456 | 60029020 | 1.69 | 75 | null | 2018-05-31 | 2018-06-05 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100000101 |
| 190009854 | 190002882 | null | null | null | null | 2016-08-26 | OST Euramos 1 Closed Trial - AP | null | null | DOXORUBICIN + HD MTX | 100000105 |
| 190009854 | 190005000 | null | 88.25 | Palliative (P) | 2016-05-20 | 2016-10-03 | EW EuroEwing 2012 Arm B IE | N | Y | EW EUROEWING 2012 ARM B IE | 100000105 |
| 190009854 | 190006245 | null | 90.5 | Palliative (P) | 2016-11-07 | 2016-11-07 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100000105 |
| 70096447 | 70109315 | 1.72 | 62 | Curative (C) | 2018-03-12 | 2018-03-19 | AML17 TRIAL | 02 | null | IXAZOMIB | 100000117 |
| 70096447 | 70160593 | 1.54 | 68 | 03 | 2018-06-14 | 2018-06-20 | AML17 TRIAL | 02 | N | MELPHALAN + THALIDOMIDE | 100000117 |
| 70096447 | 70140062 | 1.76 | 65.6 | null | 2018-05-23 | 2018-05-23 | FLAG + Idarubicin | 02 | null | FLAG + IDARUBICIN | 100000117 |
| 70096447 | 70062496 | 0 | 14.7 | Curative (C) | 2018-01-06 | 2018-01-14 | ALL UKALL2011 TRIAL | null | null | OEPA | 100000117 |
| 40119499 | 40085649 | 1.62 | 56.3 | Adjuvant (A) | 2018-08-06 | 2018-08-06 | FEC | 02 | N | FEC | 100000119 |
| 40119499 | 40170766 | 1.88 | 80 | Adjuvant (A) | 2018-08-04 | 2018-10-06 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100000119 |
| 20058820 | 20016163 | 1.77 | 79.5 | Palliative (P) | 2017-12-03 | 2017-12-09 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100000123 |
| 70022059 | 70079758 | 1.7 | 57 | 03 | 2019-03-04 | 2019-05-11 | Rituximab | 02 | N | RITUXIMAB | 100000134 |
| 70022059 | 70016931 | 1.6 | 64.6 | Curative (C) | 2016-08-12 | 2016-08-24 | CHOP R - 21 days | 02 | N | CHOP R | 100000134 |
| 40111047 | 40079538 | 1.73 | 98.55 | Neo-adjuvant (N) | 2018-12-22 | 2019-01-02 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100000135 |
| 40111047 | 40164892 | 1.59 | 76.3 | Curative (C) | 2018-12-24 | 2019-01-02 | Trastuzumab | 02 | N | TRASTUZUMAB | 100000135 |
| 60102706 | 60062698 | 1.7 | 59.4 | null | 2018-07-28 | 2018-08-26 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + PEMETREXED | 100000146 |
| 60102706 | 60038605 | 1.61 | 52.8 | Palliative (P) | 2017-09-08 | 2017-09-20 | GemCarbo Days 1+8 | N | N | GEMCARBO | 100000146 |
| 60102706 | 60076373 | 1.63 | 70.2 | null | 2021-08-13 | 2021-08-14 | Pemetrexed | 02 | null | PEMETREXED | 100000146 |
| 60102706 | 60083352 | 1.59 | 76 | Palliative (P) | 2022-03-10 | 2022-03-11 | CAV | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100000146 |
| 20035408 | 20088865 | 1.7 | 84.9 | 03 | 2019-09-24 | 2019-09-30 | null | null | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100000150 |
| 20035408 | 20085946 | 1.85 | 53.5 | Palliative (P) | 2019-02-27 | 2019-03-13 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | GEMCITABINE + PACLITAXEL | 100000150 |
| 70019149 | 70014677 | 1.67 | 73.3 | Palliative (P) | 2018-11-02 | 2018-11-03 | CHOP R - 21 days | 2 | N | CHOP R | 100000152 |
| 70019149 | 70078267 | 1.43 | 91.65 | null | 2018-12-02 | 2018-12-07 | Rituximab | 02 | null | RITUXIMAB | 100000152 |
| 70069611 | 70044522 | 1.71 | 64.1 | Disease modification (D) | 2017-01-20 | 2017-01-20 | CVP R | 02 | N | CVD | 100000154 |
| 70069611 | 70097338 | 0 | 57 | Curative (C) | 2016-09-05 | 2017-02-18 | ALL UKALL2011 Del Int B Pt1 (PAsp) | 02 | N | UKALL2011 | 100000154 |
| 70069611 | 70131565 | 0 | 0 | Curative (C) | 2016-04-18 | 2017-03-20 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | N | UKALL2011 | 100000154 |
| 70069611 | 70154606 | 1.62 | 78.95 | null | 2017-03-22 | 2017-04-05 | CTD Attenuated (Thalidomide 50mg) | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100000154 |
| 70069611 | 70180754 | 1.61 | 82.6 | null | 2017-05-28 | 2017-05-28 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 100000154 |